Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/2, randomized, active-controlled, dose escalation, multicenter trial study of Z-1018 compared to Shingrix in healthy adults aged 50 to 69 years

Next Previous
Trial Profile

A Phase 1/2, randomized, active-controlled, dose escalation, multicenter trial study of Z-1018 compared to Shingrix in healthy adults aged 50 to 69 years

Status: Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 17 Jan 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Z 1018 (Primary)
  • Indications Herpes zoster; Varicella zoster virus infections
  • Focus Adverse reactions; Pharmacodynamics

Most Recent Events

  • 13 Jan 2025 According to a Dynavax media release, In the fourth quarter of 2024, the Company completed enrollment in the trial, and Dynavax anticipates reporting top line immunogenicity and safety data in the third quarter of 2025.
  • 13 Jan 2025 According to a Dynavax media release, Status changed from recruiting to active, no longer recruiting.
  • 27 Jun 2024 Status changed from planning to recruiting, according to a Dynavax media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top